FDA OKs Automatic Use of a Cheaper Generic Insulin
THURSDAY, July 29, 2021 (HealthDay News) — U.S. pharmacists will now be able to automatically substitute a cheaper biosimilar for a more expensive brand-name insulin, the U.S Food and Drug Administration announced Wednesday. The agency’s approval of an “interchangeable” biosimilar could save diabetics and health plans millions each year, theContinue Reading